Cosentyx Prior Authorization Resources

Find the right PA form for your patient's payer, get the ICD-10 codes you need, and download appeal templates — all in one place.

Last verified: Apr 24, 2026

Blue Cross Blue Shield of Arkansas - Pharmacy Prior Authorization Form Arkansas Blue Cross Blue Shield · Updated Apr 24, 2026
Blue Cross of Idaho - General Prior Authorization Form Blue Cross of Idaho Health Services, Inc. · Updated Apr 24, 2026
California - Uniform Prior Authorization FormCalifornia · Updated Apr 16, 2026
CDPHP - General Prior Authorization FormCapital District Physicians Health Plan, Inc. · Updated Apr 24, 2026
Cigna - General Medication Prior Authorization FormCigna Corporation · Updated Apr 24, 2026
Colorado - Uniform Prior Authorization FormColorado · Updated Apr 16, 2026

ICD-10 codes for Cosentyx Prior Authorizations

L40.0Psoriasis vulgaris
L40.50Arthropathic psoriasis, unspecified
M45.0Ankylosing spondylitis of multiple sites in spine
M45.1Ankylosing spondylitis of occipito-atlanto-axial region
M45.9Ankylosing spondylitis of unspecified sites in spine
M45.8Ankylosing spondylitis sacral and sacrococcygeal region
M08.9Juvenile arthritis, unspecified
L73.2Hidradenitis suppurativa

Appeal Templates

If the payer denies coverage, these templates help you build a stronger appeal.
Coverage Authorization AppealsCoverage Authorization Appeals resource
PA Exceptions & Appeals KitPA Exceptions & Appeals Kit resource
A peer-to-peer review with the payer's medical director can often resolve denials faster than a formal appeal.

Brand Resources

How To Order Cosentyx [IV Distributors]How To Order Cosentyx [IV Distributors] resource
Coverage Authorization RequestCoverage Authorization Request resource
Medical Exception Request Letter Medical Exception Request Letter resource

Support for Getting Your Patient on Cosentyx

Check coverage & formulary statusVerify PA requirements for your patient's plan.Find savings programsCopay cards, patient assistance, and more.Check medication interactionsScreen prescriptions for harmful drug combinations.